Bokf Na lifted its position in Colgate-Palmolive (NYSE:CL – Free Report) by 37.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 95,411 shares of the company’s stock after buying an additional 26,188 shares during the period. Bokf Na’s holdings in Colgate-Palmolive were worth $9,259,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. Union Savings Bank boosted its holdings in Colgate-Palmolive by 76.6% during the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after buying an additional 134 shares in the last quarter. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $25,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter worth $32,000. PSI Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after purchasing an additional 348 shares during the last quarter. Finally, Core Wealth Advisors Inc. boosted its position in shares of Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after purchasing an additional 146 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Stock Up 0.2 %
Colgate-Palmolive stock opened at $106.35 on Friday. The company has a market capitalization of $87.25 billion, a P/E ratio of 33.66, a P/E/G ratio of 3.78 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $109.30. The firm’s fifty day simple moving average is $101.93 and its 200-day simple moving average is $95.04. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.88%. Colgate-Palmolive’s payout ratio is currently 63.29%.
Insider Buying and Selling at Colgate-Palmolive
In related news, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the sale, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at $1,069,868.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 over the last 90 days. Insiders own 0.34% of the company’s stock.
Analyst Ratings Changes
A number of analysts have commented on CL shares. BNP Paribas assumed coverage on shares of Colgate-Palmolive in a research note on Monday, June 24th. They set an “outperform” rating and a $109.00 price objective for the company. UBS Group upped their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $107.00 to $109.00 in a research report on Monday. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Finally, Citigroup lifted their price target on Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $102.63.
Get Our Latest Research Report on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Leveraged ETFs to Multiply Returns
- What Investors Need to Know About Upcoming IPOs
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- What is MarketRankā¢? How to Use it
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.